Recurrent Non-small Cell Lung Cancer Completed Phase 2 / 3 Trials for Paclitaxel (DB01229)

Also known as: Non-Small Cell Lung Cancer Recurrent / Lung cancer non-small cell recurrent

IndicationStatusPhase
DBCOND0028805 (Recurrent Non-small Cell Lung Cancer)Completed2 / 3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00021060Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurrent Non-Small Cell Lung CancerTreatment